IGF1R and triple-negative breast carcinoma: A recent meta-analysis of ten independent studies evaluating cytoplasmic and membrane staining of IGF1R in breast cancer patients concluded that IGF1R was associated with better outcome in hormone receptor positive cancers, but with poor survival in triple-negative breast cancers [20].